Document Detail

MRP expression in acute myeloid leukemia. An update.
MedLine Citation:
PMID:  10500789     Owner:  NLM     Status:  MEDLINE    
To determine the clinical significance of the multidrug resistance protein (MRP) in patients with de novo AML, we have studied MRP expression of leukemic cells at diagnosis and its association with clinical outcome in 127 patients. MRP expression was determined by immunocytochemistry by means of monoclonal antibodies QCRL-1/QCRL-3. MRP expression was low, intermediate and high in 30%, 46% and 24% of the patients, respectively. MRP expression was independent of age and sex of the patients, white blood cell count, FAB subtype, serum lactate dehydrogenase levels and karyotype aberrations. MRP expression had no impact no response to induction chemotherapy. The complete remission rates were 75%, 70% and 64% for patients with low, intermediate and high expression, respectively. Patients with intermediate or high MRP expression showed a trend toward shorter overall survival (p = 0.09) as compared to patients with low MRP expression. MRP does not predict for response to induction chemotherapy but intermediate or high MRP expression might be associated with shorter overall survival of the patients.
M Filipits; T Stranzl; G Pohl; R W Suchomel; S Zöchbauer; R Brunner; K Lechner; R Pirker
Related Documents :
8722369 - Polymerase chain reaction is highly predictive of relapse in patients following t cell-...
16260859 - Spontaneous remission in adults with primary myelodysplastic syndromes: incidence and c...
9264379 - Rearrangement status of the malignant cell determines type of secondary igh rearrangeme...
10764149 - Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elde...
8642049 - Clinical implications of cytogenetic classification in adult acute lymphoblastic leukae...
3617109 - Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemi...
24641929 - Lifting disabled patients onto the densitometer with a ceiling-lift; effect of the slin...
15287949 - Activated protein c levels in behçet's disease and risk of venous thrombosis.
22233829 - Impact of taenia solium neurocysticercosis upon endocrine status and its relation with ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Advances in experimental medicine and biology     Volume:  457     ISSN:  0065-2598     ISO Abbreviation:  Adv. Exp. Med. Biol.     Publication Date:  1999  
Date Detail:
Created Date:  1999-11-04     Completed Date:  1999-11-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0121103     Medline TA:  Adv Exp Med Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  141-50     Citation Subset:  IM    
Department of Internal Medicine I, University of Vienna Medical School, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Disease-Free Survival
Drug Resistance, Multiple*
Leukemia, Myeloid, Acute / drug therapy*,  genetics,  mortality,  pathology
Middle Aged
P-Glycoprotein / analysis,  genetics*
Remission Induction
Survival Rate
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia.
Next Document:  Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance as...